Novel Prognostic Model Based on Immune Signature for Head and Neck Squamous Cell Carcinoma

Figure 1

Workflow demonstrating the establishment and validation of a prognostic predictive model in HNSCC. The signature consists of 35 immune-related genes in HNSCC, which was established and validated using expression data from the TCGA database (training dataset).